The most informative approach would involve applying the same methods in participants with Rett syndrome, MECP2 duplication syndrome, CDD, FOXG1 disorder, and TD controls to directly assess how EP and EEG measures in these disorders vary compared to TD and one another. This evidence concerns the gene MECP2 and atypical Rett syndrome.